Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA3 | P22001 | 1/20 | 0.50 |
| ▸ | LTA4H | P09960 | 2/20 | 0.46 |
| ▸ | HTR1B | P28222 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | HTR1D | P28221 | 1/20 | 0.45 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.42 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.42 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.42 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.42 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.42 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.42 |
| ▸ | CA4 | P22748 | 1/20 | 0.42 |
| ▸ | GABRP | O00591 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13141341 | 0.87 | NQO1 (0.48) | LTA4HALDH1A1PDK2GABRPGABRD | |
| SCHEMBL7462021 | 0.87 | NPC1 (0.51) | LTA4HLMNAALDH1A1CHRNB2CHRNB4 | |
| SCHEMBL4984322 | 0.85 | KCNA3 (0.50) | KCNA3LTA4HHTR1BLMNAHTR1D | |
| SCHEMBL2200517 | 0.85 | KCNA3 (0.50) | KCNA3LTA4HHTR1BLMNAHTR1D | |
| SCHEMBL10645031 | 0.84 | ALOX15 (0.41) | KCNA3LMNAALDH1A1RECQLCYP2D6 | |
| SCHEMBL12250936 | 0.83 | LMNA (0.60) | LMNA | |
| SCHEMBL10534532 | 0.83 | PDK2 (0.45) | LMNAALDH1A1PDK2CHRNB2CHRNA4 | |
| SCHEMBL10713342 | 0.82 | KCNA3 (0.43) | KCNA3LTA4HHTR1BLMNAHTR1D | |
| SCHEMBL12250931 | 0.82 | GGPS1 (0.56) | LTA4HPDK2 | |
| SCHEMBL25053084 | 0.81 | KCNA3 (0.46) | KCNA3LTA4HHTR1BLMNAHTR1D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 248 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4277591-A1 | ETHER COMPOUNDS AS VOLATILES FOR THE TREATMENT OF AMINO ACID BASED SUBSTRATES, SUCH AS SKIN AND HAIR | Momentive Performance Materials GmbH (DE) | 2023-11-22 | — | — | EP | claimed |
| CN-116670108-A | Ether compounds as volatiles for treating amino acid based substrates such as skin and hair | 迈图高新材料有限责任公司 | 2023-08-29 | — | — | CN | claimed |
| WO-2022152742-A1 | ETHER COMPOUNDS AS VOLATILES FOR THE TREATMENT OF AMINO ACID BASED SUBSTRATES, SUCH AS SKIN AND HAIR | MOMENTIVE PERFORMANCE MATERIALS GMBH (DE) | 2022-07-21 | — | — | WO | claimed |
| EP-3203541-B1 | ORGANIC SEMICONDUCTOR COMPOSITION | FUJIFILM CORP (JP) | 2022-07-06 | — | — | EP | claimed |
| EP-3203541-A1 | ORGANIC SEMICONDUCTOR COMPOSITION AND ORGANIC SEMICONDUCTOR ELEMENT | Fujifilm Corporation (JP) | 2017-08-09 | — | — | EP | claimed |
| US-20170125694-A1 | ORGANIC SEMICONDUCTOR COMPOSITION AND ORGANIC SEMICONDUCTOR ELEMENT | FUJIFILM CORPORATION (JP) | 2017-05-04 | — | — | US | claimed |
| EP-2266949-B1 | \"Fast, high-efficiency quantitative synthesis of paracetamol\ | GREGORIO LIBERATA (IT) | 2013-05-29 | — | — | EP | claimed |
| EP-2266949-A1 | \"Fast, high-efficiency quantitative synthesis of paracetamol\ | Gregoria, Liberata (IT) | 2010-12-29 | — | — | EP | claimed |
| US-12350296-B2 | Liquid propolis extract, its formulation and use thereof | ApiotiX Technologies d.o.o. (HR) | 2025-07-08 | — | — | US | disclosed |
| WO-2024078851-A1 | CATALYTIC COMPOSITIONS | Universität Heidelberg (DE) | 2024-04-18 | — | — | WO | disclosed |
| US-20240018298-A1 | OLEFINIC COMPOSITIONS COMPRISING HYDROCARBON RESINS | ExxonMobil Product Solutions Company | 2024-01-18 | — | — | US | disclosed |
| US-20240018298-A1 | OLEFINIC COMPOSITIONS COMPRISING HYDROCARBON RESINS | ExxonMobil Product Solutions Company | 2024-01-18 | — | — | US | disclosed |
| US-20230372292-A1 | TREATMENTS OF CORONAVIRUS INFECTIONS, CYTOKINE RELEASE SYNDROME, CYTOKINE STORM SYNDROME, OR DISEASES ASSOCIATED WITH EXCESSIVE ACTIVATION OF INFLAMMASOMES BY THE USE OF INHIBITORS OF INFLAMMATORY CASPASES | IPCURE S.A.S. (FR) | 2023-11-23 | — | — | US | disclosed |
| US-11786575-B2 | Endoparasitic depsipeptides | ZOETIS SERVICES LLC (US) | 2023-10-17 | — | — | US | disclosed |
| EP-0977743-A1 | PROTEASE INHIBITORS | Smithkline Beecham (US) | 2000-02-09 | — | — | EP | disclosed |
| WO-1998049152-A1 | PROTEASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 1998-11-05 | — | — | WO | disclosed |
| US-4837301-A | FROM ALKALI MTEAL SULFIDES AND AROMATIC DIHALOGEN COMPOUNDS; IMPROVED CORROSION RESISTANCE | BAYER AKTIENGESELLSCHAFT (DE) | 1989-06-06 | — | — | US | disclosed |
| EP-0275007-A2 | Process for the preparation of highly molecular, optionally branched polyarylene sulfides | BAYER AG (DE) | 1988-07-20 | — | — | EP | disclosed |
| EP-0273242-A2 | 2-Pyri(mi)dylthio-aryl ether | BAYER AG (DE) | 1988-07-06 | — | — | EP | disclosed |
| US-4066707-A | METHOD FOR MANUFACTURE OF DIPHENOLS AND MONOALKYL ETHERS OF DIPHENOLS | AGENCY OF INDUSTRIAL SCIENCE & TECHNOLOGY (JA) | 1978-01-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11786575-B2 | Endoparasitic depsipeptides | VIP, PREP, NGLY1 | KCNA3 3161/4885LTA4H 256/4885HTR1B 2340/4885 |
| US-12350296-B2 | Liquid propolis extract, its formulation and use thereof | CUTA, LITAF, ALB | KCNA3 4511/4885LTA4H 764/4885HTR1B 4881/4885 |
| US-20230372292-A1 | TREATMENTS OF CORONAVIRUS INFECTIONS, CYTOKINE RELEASE SYNDROME, CYTOKINE STORM SYNDROME, OR DISEASES ASSOCIATED WITH EXCESSIVE ACTIVATION OF INFLAMMASOMES BY THE USE OF INHIBITORS OF INFLAMMATORY CASPASES | CASP1, IL1B, PYCARD | KCNA3 1904/4885LTA4H 414/4885HTR1B 2680/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.